ARCHIVES

Drug Development: ODAC Discussion May Offer Clues For Sponsors of Cytostatic Drugs

This article is from The Cancer Letter archive.

Vol. 25 No. 24 | June 16, 1999

Download PDF Visit The Full Archive

Related Articles

Breast Implants Lessen Ability Of Mammograms To Find Cancer

February 27, 2004

Preventive Ovarian Surgery Recommended For Women with BRCA1 Mutations by Age 35

February 28, 2014

DCPC Board approves New CCOP RFA Following Addition Of Public Health, Education Components

May 16, 1986

Symptoms Don’t Help Detect Early-Stage Ovarian Cancer

February 26, 2010

VeriStrat Biomarker Test Predicts Treatment Outcomes In Phase III NSCLC Trial

May 30, 2014

Cancer Control Seeks Grant Applications In Three Interventions Areas And In Community Development

September 13, 1974